C16 Biosciences is a biotechnology startup established in 2018, headquartered in the United States. The company's mission is to utilize microbiology to produce sustainable, conflict-free palm oil, aiming to reduce global CO2 emissions. C16 Biosciences recognizes the significant environmental and social impact of the palm oil industry, with rainforest destruction and carbon dioxide release being major concerns. The company is determined to address these issues by providing a sustainable alternative to palm oil through innovative biological processes. It has received a $1.00M investment in its latest Venture Round, with Elemental Excelerator as the investor on 26 January 2024. C16 Biosciences' unique approach of brewing palm oil from microbes through fermentation technology presents a promising solution for transforming the palm oil industry into a more environmentally conscious and sustainable sector. This approach has the potential to mitigate deforestation, protect wildlife, and promote ethical labor practices, offering consumers the products they love without the associated environmental and ethical concerns.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $1.00M | 1 | 26 Jan 2024 | |
Grant | $3.50M | 1 | 24 Jan 2024 | |
Grant | $50.00K | 1 | 04 Nov 2023 | |
Convertible Note | Unknown | 1 | 18 Oct 2023 | |
Series A | Unknown | 2 | New York Ventures | 26 Apr 2023 |
No recent news or press coverage available for C16 Biosciences.